Boot H - Search Results

1

Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.

Helgason HH, Engwegen JY, Zapatka M, Vincent A, Cats A, Boot H, Beijnen JH, Schellens JH. Helgason HH, et al. Among authors: boot h. Oncol Rep. 2010 Jul;24(1):57-64. doi: 10.3892/or_00000828. Oncol Rep. 2010. PMID: 20514444

2

Serum proteomics and disease-specific biomarkers of patients with advanced gastric cancer.

Helgason HH, Engwegen JY, Zapatka M, Cats A, Boot H, Beijnen JH, Schellens JH. Helgason HH, et al. Among authors: boot h. Oncol Lett. 2010 Mar;1(2):327-333. doi: 10.3892/ol_00000058. Epub 2010 Mar 1. Oncol Lett. 2010. PMID: 22966303 Free PMC article.

3

Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.

Deenen MJ, Dewit L, Boot H, Beijnen JH, Schellens JH, Cats A. Deenen MJ, et al. Among authors: boot h. Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):e201-7. doi: 10.1016/j.ijrobp.2012.12.008. Int J Radiat Oncol Biol Phys. 2013. PMID: 23517808 Clinical Trial.

4

The prognostic significance of an R1 resection in gastric cancer patients treated with adjuvant chemoradiotherapy.

Stiekema J, Trip AK, Jansen EP, Boot H, Cats A, Ponz OB, Verheij M, van Sandick JW. Stiekema J, et al. Among authors: boot h. Ann Surg Oncol. 2014 Apr;21(4):1107-14. doi: 10.1245/s10434-013-3397-4. Epub 2013 Dec 4. Ann Surg Oncol. 2014. PMID: 24306660

5

Does adjuvant chemoradiotherapy improve the prognosis of gastric cancer after an r1 resection? Results from a dutch cohort study.

Stiekema J, Trip AK, Jansen EP, Aarts MJ, Boot H, Cats A, Ponz OB, Gradowska PL, Verheij M, van Sandick JW. Stiekema J, et al. Among authors: boot h. Ann Surg Oncol. 2015 Feb;22(2):581-8. doi: 10.1245/s10434-014-4032-8. Epub 2014 Aug 28. Ann Surg Oncol. 2015. PMID: 25164039

6

Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction.

Deenen MJ, Meulendijks D, Boot H, Legdeur MC, Beijnen JH, Schellens JH, Cats A. Deenen MJ, et al. Among authors: boot h. Cancer Chemother Pharmacol. 2015 Dec;76(6):1285-95. doi: 10.1007/s00280-015-2872-y. Epub 2015 Oct 23. Cancer Chemother Pharmacol. 2015. PMID: 26499900 Clinical Trial.

7

Upfront Genotyping of DPYD*2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis.

Deenen MJ, Meulendijks D, Cats A, Sechterberger MK, Severens JL, Boot H, Smits PH, Rosing H, Mandigers CM, Soesan M, Beijnen JH, Schellens JH. Deenen MJ, et al. Among authors: boot h. J Clin Oncol. 2016 Jan 20;34(3):227-34. doi: 10.1200/JCO.2015.63.1325. Epub 2015 Nov 16. J Clin Oncol. 2016. PMID: 26573078 Clinical Trial.

8

Trastuzumab and bevacizumab combined with docetaxel, oxaliplatin and capecitabine as first-line treatment of advanced HER2-positive gastric cancer: a multicenter phase II study.

Meulendijks D, Beerepoot LV, Boot H, de Groot JW, Los M, Boers JE, Vanhoutvin SA, Polee MB, Beeker A, Portielje JE, de Jong RS, Goey SH, Kuiper M, Sikorska K, Beijnen JH, Tesselaar ME, Schellens JH, Cats A. Meulendijks D, et al. Among authors: boot h. Invest New Drugs. 2016 Feb;34(1):119-28. doi: 10.1007/s10637-015-0309-4. Epub 2015 Dec 8. Invest New Drugs. 2016. PMID: 26643663 Clinical Trial.

9

Outcome of low-volume surgery for esophageal cancer in a high-volume referral center.

Courrech Staal EF, van Coevorden F, Cats A, Aleman BM, van Velthuysen ML, Boot H, Peeters MJ, van Sandick JW. Courrech Staal EF, et al. Among authors: boot h. Ann Surg Oncol. 2009 Dec;16(12):3219-26. doi: 10.1245/s10434-009-0700-5. Epub 2009 Sep 24. Ann Surg Oncol. 2009. PMID: 19777184

10

Clinical and pharmacologic study of the farnesyltransferase inhibitor tipifarnib in cancer patients with normal or mildly or moderately impaired hepatic function.

Siegel-Lakhai WS, Crul M, De Porre P, Zhang S, Chang I, Boot H, Beijnen JH, Schellens JH. Siegel-Lakhai WS, et al. Among authors: boot h. J Clin Oncol. 2006 Oct 1;24(28):4558-64. doi: 10.1200/JCO.2006.05.8123. J Clin Oncol. 2006. PMID: 17008695 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page